Evidence map›Paper›PMID 24642609›Full record

ArticlePLoS biology2014

A tetraploid intermediate precedes aneuploid formation in yeasts exposed to fluconazole.

Benjamin D Harrison, Jordan Hashemi, Maayan Bibi, Rebecca Pulver, Danny Bavli, Yaakov Nahmias, Melanie Wellington, Guillermo Sapiro, Judith Berman

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 120 papers.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

120 citing papers in PubMed, 182 citations in OpenAlex.

  1. Review
  2. Article
  3. Growth under pressure: The pros and cons of polyploidy induced by stress.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Review
  4. Genetic and environmental control of parasexual reproduction in the pathogenicMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Genome research · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Benjamin D HarrisonDepartment of Genetics, Cell, and Developmental Biology, University of Minnesota-Twin Cities, Minneapolis, Minnesota, United States of America.
Jordan HashemiDepartment of Electrical and Computer Engineering, Duke University, Durham, North Carolina, United States of America.
Maayan BibiDepartment of Molecular Microbiology and Biotechnology, Tel Aviv University, Tel Aviv, Israel.
Rebecca PulverDepartment of Molecular Microbiology and Biotechnology, Tel Aviv University, Tel Aviv, Israel.
Danny BavliAlexander Grass Center for Bioengineering, The Hebrew University of Jerusalem, Jerusalem, Israel.
Yaakov NahmiasAlexander Grass Center for Bioengineering, The Hebrew University of Jerusalem, Jerusalem, Israel.
Melanie WellingtonDepartment of Pediatrics, University of Rochester Medical Center, Rochester, New York, United States of America.
Guillermo SapiroDepartment of Electrical and Computer Engineering, Duke University, Durham, North Carolina, United States of America.
Judith BermanDepartment of Genetics, Cell, and Developmental Biology, University of Minnesota-Twin Cities, Minneapolis, Minnesota, United States of America; Department of Molecular Microbiology and Biotechnology, Tel Aviv University, Tel Aviv, Israel.
Duke University · USHebrew University of Jerusalem · ILTel Aviv University · ILUniversity of Minnesota · USUniversity of Rochester Medical Center · US

Funding

MINNESOTA PAIN RESEARCH TRAINING PROGRAMT32DE007288 · NIDCR · UNIVERSITY OF MINNESOTA TWIN CITIES · PI HERZBERG, MARK C · 1996 to 2011
$8.8M
European Research Council 340087NIAID NIH HHS R01AI0624273NIDCR NIH HHS T32 DE007288NIDCR NIH HHS T32DE007288
6 · The paper itself

Abstract

Candida albicans, the most prevalent human fungal pathogen, is generally diploid. However, 50% of isolates that are resistant to fluconazole (FLC), the most widely used antifungal, are aneuploid and some aneuploidies can confer FLC resistance. To ask if FLC exposure causes or only selects for aneuploidy, we analyzed diploid strains during exposure to FLC using flow cytometry and epifluorescence microscopy. FLC exposure caused a consistent deviation from normal cell cycle regulation: nuclear and spindle cycles initiated prior to bud emergence, leading to "trimeras," three connected cells composed of a mother, daughter, and granddaughter bud. Initially binucleate, trimeras underwent coordinated nuclear division yielding four daughter nuclei, two of which underwent mitotic collapse to form a tetraploid cell with extra spindle components. In subsequent cell cycles, the abnormal number of spindles resulted in unequal DNA segregation and viable aneuploid progeny. The process of aneuploid formation in C. albicans is highly reminiscent of early stages in human tumorigenesis in that aneuploidy arises through a tetraploid intermediate and subsequent unequal DNA segregation driven by multiple spindles coupled with a subsequent selective advantage conferred by at least some aneuploidies during growth under stress. Finally, trimera formation was detected in response to other azole antifungals, in related Candida species, and in an in vivo model for Candida infection, suggesting that aneuploids arise due to azole treatment of several pathogenic yeasts and that this can occur during the infection process.

Indexed as

AneuploidyTetraploidyAntifungal AgentsCandida albicansCell EnlargementDrug Resistance, FungalFluconazoleAntifungal AgentsFluconazole

Identifiers

PMID24642609
PMCPMC3958355
OpenAlexW1974859219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.